Ascend Capital’s Itron ITRI Stock Holding History

Ascend Capital’s Portfolio ITRI Stock Details ITRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-109,505	Closed	-$7.83M	–	201
2018 Q1	$7.83M	Buy	+109,505	New	+$7.84M	0.32%	101

Other funds holding ITRI

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAMU

Impax Asset Management (UK) London, United Kingdom $4.12B AUM 10.79% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MCM

Marcato Capital Management San Francisco, California $1.2M AUM 91.17% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Ascend Capital's ITRI Position: Q2 2018 in Review

Ascend Capital sold out of Itron (ITRI) in Q2 2018, closing a stake of 109,505 shares — an estimated $7.83M sold.

Ascend Capital first reported a position in ITRI in Q1 2018 and held it in 1 quarter. The position peaked at $7.83M in Q1 2018. 220 funds tracked by Wall St. Rank hold ITRI as of Q2 2018.

Ascend Capital reported no remaining Itron position as of Q2 2018 after selling out during the quarter.
Ascend Capital sold 109,505 Itron shares in Q2 2018, an estimated $7.83M.
Ascend Capital first reported a position in Itron in Q1 2018 and held it in 1 quarter.
Ascend Capital's Itron position peaked at $7.83M in Q1 2018.
220 funds tracked by Wall St. Rank held Itron as of Q2 2018.

Based on Ascend Capital's 13F filing for Q2 2018, filed 13 Aug 2018.